Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Bova UK confirms omeprazole ‘free from testosterone’
“Many vets and horse owners now rely on long acting injectable omeprazole for horses that do not respond to oral treatment.”

New batch tested following concerns from the racing industry

Drug company Bova UK has confirmed its long-acting injectable omeprazole has been declared free from testosterone, after low levels were found in the product last month.

Supply of the product ceased in Australia after the initial discovery by the New South Wales racing authority.

Samples tested by the British Horseracing Authority (BHA) confirmed the issue extended to the UK and the racing body recently advised against using injectible omeprazole in racehorses.

Testing by the Australian Racing Forensic Laboratory (ARFL) did not detect testosterone in the newly prepared batch of Bova’s 100mg/ml injectable omeprazole formulation.

Racing New South Wales released a statement to confirm that the product can continue to be used in racehorses following the guidance of Australian Commonwealth and State legislation.

Nick Bova, the firm’s managing director, said: “Traces of testosterone in the previous batch were less than one millionth of the internationally accepted standard for impurities. Independent experts confirmed that there could be no adverse effects on equine health or equestrian sport, however, we have taken steps to identify and completely eliminate the excipient ingredient that contained traces of testosterone.

“Bova can confirm that new batches of this product will not contain the previous trace levels of testosterone and therefore Bova are confident there will be no antidoping issues, no matter what the equestrian pursuit is.”

He added: “Many vets and horse owners now rely on long acting injectable omeprazole for horses that do not respond to oral treatment.”

Following the news, the BHA issued an updated statement on the use of the product: “The BHA are aware of the most recent results from the batch analysed in Australia. Anyone treating thoroughbreds from birth to retirement from racing should consider the latest information, alongside that from analysis of previous batches, in deciding whether to use the product.”

 

Become a member or log in to add this story to your CPD history

AWF Student Grant Scheme opens for applications

News Story 1
 The Animal Welfare Foundation (AWF) is inviting applications to its 2021 Student Grant Scheme for innovative projects designed to impact animal welfare. The scheme welcomes proposals from undergraduates studying veterinary and animal welfare degrees, but students from other disciplines are also welcome to apply.

Grants will fund projects on animal welfare topics that are relevant to the veterinary profession and help develop the student's skills as a researcher. This year, the AWF is also accepting projects which are carried out alongside EMS so long as they are supervised. For more information and to apply, visit animalwelfarefoundation.org.uk 

Click here for more...
News Shorts
Survey seeks views on keeping cows with calves

Researchers at Scotland's Rural College are seeking views from dairy farmers on keeping cows with calves.

Their study entitled 'Keeping Cow with Calf: bringing innovation to dairying in Scotland' aims to find out the motivations and reservations about operating a cow-with-calf dairy system.

The survey will help researchers build an evidence base and gauge what support farmers need to move to this practice. For more information, or to complete the survey, visit keepingcowwithcalf.com